Triple-negative breast cancer: from none to multiple therapeutic targets in two decades (2023)
Fonte: Frontiers in oncology. Unidade: FM
Assuntos: NEOPLASIAS MAMÁRIAS, ESTRATÉGIAS TERAPÊUTICAS, PROGNÓSTICO, IMUNOTERAPIA
ABNT
CARVALHO, Filomena Marino. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades. Frontiers in oncology, v. 13, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57524. Acesso em: 12 nov. 2024.APA
Carvalho, F. M. (2023). Triple-negative breast cancer: from none to multiple therapeutic targets in two decades. Frontiers in oncology, 13. doi:10.3389/fonc.2023.1244781NLM
Carvalho FM. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades [Internet]. Frontiers in oncology. 2023 ; 13[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57524Vancouver
Carvalho FM. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades [Internet]. Frontiers in oncology. 2023 ; 13[citado 2024 nov. 12 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57524